register

News & Trends - MedTech & Diagnostics

Aussie medtech partners with Philips to expand access to lung screening

Health Industry Hub | January 24, 2024 |

MedTech & Diagnostics News: Australian-based company specialising in four-dimensional lung imaging has inked a pivotal commercial agreement with global medtech Philips. The collaboration aims to evaluate Veterans dealing with deployment-related respiratory diseases (DRRD), interstitial lung disease (ILD), and various other respiratory illnesses.

Under the terms of the agreement, 4DMedical and Philips will join forces to pioneer innovative lung screening solutions, leveraging the capabilities of 4DMedical’s cutting-edge software alongside Philips’ fluoroscopy and CT systems. The ultimate goal is to solidify a reseller agreement, wherein 4DMedical’s XV Technology and Imbio portfolio will become integral components of Philips’ product catalogue, providing a comprehensive third-party solution encompassing both software and hardware. The collaborative effort also aspires to extend its reach beyond the United States.

Philips has already made strides in addressing respiratory health challenges in underserved communities, including in Australia. The incidence of lung cancer in regional, rural, and remote areas of Australia is approximately 30% higher than the national average. Recognising this health disparity, Philips partnered with Heart of Australia to pioneer a solution.

Philips’ engineering team collaborated with Heart of Australia to design the world’s first solar and battery-powered low-dose CT scanner housed in a ruggedised 26-meter B-double truck. This innovative mobile unit overcame the challenges posed by the rough terrain of the Australian outback and off-road locations lacking stable electricity supply. The unit operates independently in terms of power requirements, while an advanced tele-PACS communication system enables remote clinicians to view CT scans promptly, make diagnoses, and determine optimal treatment plans.

Professor Catherine Jones, lead radiologist at Heart of Australia, emphasised the transformative impact of the mobile CT unit, stating “People exposed to dust and respiratory hazards in mines, has been a significant issue with many miners developing mine dust lung diseases. Miners now get much more than just a CT chest scan. They get a comprehensive health assessment including lung function, occupational health checks, and hearing tests. We coordinate with the whole care team to discuss what could be wrong with each patient and how best to treat them next. It’s much more than just taking a scan and moving on to the next mining town,”

In its inaugural year of operation, Heart of Australia’s mobile CT unit provided over 2500 patient consultations, conducted more than 2500 X-rays, performed over 500 CT scans, and diagnosed 159 cases of respiratory disease. Beyond its primary focus on lung health, the program has expanded its scope, with five mobile units delivering cardiology services, stress tests, ECGs, and echocardiograms, along with 10 other medical specialties, to underserved rural and remote communities.

As both 4DMedical and Philips continue to pioneer advancements in medical technology, this agreement signifies a concerted effort to address critical respiratory conditions.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the ONLY one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The exclusive leadership and influencer podcasts and vodcasts add huge value to our breaking news coverage. The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Pharmaceuticals

Manoj Saxena - Bayer

Breaking the mold: Bayer GM on the future of pharma workplaces – Reimagining Healthcare Senior Leadership Series

Health Industry Hub | July 18, 2024 |

In the latest episode of the Reimagining Healthcare senior leadership series, Manoj Saxena, General Manager Pharmaceuticals ANZ at Bayer voiced […]

More


News & Trends - Pharmaceuticals

Matt Zeller, Country President of Novartis ANZ

Novartis Country President talks essentials in shaping the future of health policy: Reimagining Healthcare senior leadership series

Health Industry Hub | July 18, 2024 |

In this episode of the Reimagining Healthcare senior leadership series, Matt Zeller, Country President of Novartis ANZ, explores how health […]

More


Medical

First guidelines to stamp out rising scientific integrity issues in medical journals

First guidelines to stamp out rising scientific integrity issues in medical journals

Health Industry Hub | July 18, 2024 |

The number of retractions issued for scientific research articles in 2023 exceeded 10,000 – smashing annual records. To date, publishers […]

More


News & Trends - Pharmaceuticals

Gilead secures MSAC nod for CAR-T therapy

Gilead secures MSAC nod for CAR-T therapy

Health Industry Hub | July 18, 2024 |

Pharma News: Gilead Sciences welcomes the Medical Services Advisory Committee (MSAC) recommendation for public funding of Yescarta (axicabtagene ciloleucel) as […]

More


This content is copyright protected. Please subscribe to gain access.